CM
ANGO icon

Crestline Management’s AngioDynamics ANGO Stock Holding History

Crestline Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-64,997
Closed -$1.79M – 261
2021
Q4 		$1.79M Buy
64,997
+48,869
+303% +$1.35M 0.13% 119
2021
Q3 		$419K Buy
+16,128
New +$431K 0.04% 175

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Crestline Management's ANGO Position: Q1 2022 in Review

Crestline Management sold out of AngioDynamics (ANGO) in Q1 2022, closing a stake of 64,997 shares — an estimated $1.79M sold.

Crestline Management first reported a position in ANGO in Q3 2021 and held it in 2 quarters. The position peaked at $1.79M in Q4 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.

  • Crestline Management reported no remaining AngioDynamics position as of Q1 2022 after selling out during the quarter.
  • Crestline Management sold 64,997 AngioDynamics shares in Q1 2022, an estimated $1.79M.
  • Crestline Management first reported a position in AngioDynamics in Q3 2021 and held it in 2 quarters.
  • Crestline Management's AngioDynamics position peaked at $1.79M in Q4 2021.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.

Based on Crestline Management's 13F filing for Q1 2022, filed 16 May 2022.